Please try another search
Spago Nanomedical publ AB, formerly Spago Imaging publ AB, is a Sweden-based biotechnology company. It specialized in the areas of contrast agents and nanoscale life science research. The Company is involved in three projects: Spago Pix, a nanomaterial developed for use as a cancer selective contrast agent for Magnetic Resonance Imaging (MRI); the therapeutic project Tumorad, using nanoparticles loaded with radionuclides for selective treatment of cancers, which are unsuitable for surgery or external radiation; and Archaea Platin, aimed at delivering of chemotherapeutic substance cisplatin selectively to tumors in order to reduce side effects on healthy tissue. The Company's technology comprises a technology platform IonXgel, which is a nano-sized biocompatible material consisting of polar polymers; a protein-based drug delivery platform, ProtRc; and 3PEG, a platform which enables attachment of polyethylene glycol (PEG) derivatives to small molecules (PEGylation).
Name | Age | Since | Title |
---|---|---|---|
Sten Nilsson | 75 | 2013 | Medical Advisor |
Peter Leander | 66 | 2012 | Medical Advisor |
Kari Gronas | 58 | 2018 | Independent Director |
Nicklas Westerholm | 47 | 2019 | Independent Director |
Alan Raffensperger | 63 | 2023 | Independent Director |
Per Hall | - | 2022 | Medical Advisor |
Hans Arwidsson | 65 | 2023 | Independent Chairman of the Board |
Kristian Pietras | - | 2023 | Medical Advisor |
Timothy Roberts | - | 2022 | Medical Advisor |
Austin Smith | - | 2023 | Medical Advisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review